Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10023879 Minimal volume reprogramming of mononuclear cells

Patent 10023879 was granted and assigned to Fate Therapeutics Inc on July, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 8 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11976084 Spiropyrrolidine derived antiviral agents
0
Edits on 30 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11879137 Treatment of type 1 diabetes and autoimmune diseases or disorders
0
Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+321 characters)
Article

Patent abstract

The invention provides compositions and methods for reprogramming minimal volumes of mononuclear cells. In particular aspects, the invention provides methods and compositions for reprogramming minimal volumes of umbilical cord blood obtained from cord blood segments from cryopreserved cord blood segments.

Edits on 10 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 10 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11642378 PD-L1 expressing hematopoietic stem cells and uses
0
Edits on 29 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Edits on 27 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
Edits on 26 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Edits on 21 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 21 Apr, 2023
Edits on 4 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2023
Edits on 2 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
100238790
Date of Patent
July 17, 2018
0
Patent Application Number
147314030
Date Filed
June 4, 2015
0
Patent Citations Received
‌
US Patent 10517899 PD-L1 expressing hematopoietic stem cells and uses
0
‌
US Patent 10751373 PD-L1 expressing hematopoietic stem cells and uses
0
‌
US Patent 11319325 Macrocyclic spiropyrrolidine derived antiviral agents
0
‌
US Patent 11325916 Spiropyrrolidine derived antiviral agents
0
‌
US Patent 11339170 Spiropyrrolidine derived antiviral agents
0
‌
US Patent 11352363 Spiropyrrolidine derived antiviral agents
0
‌
US Patent 11358953 Functionalized peptides as antiviral agents
0
‌
US Patent 11384090 Spiropyrrolidine derived antiviral agents
0
Patent Primary Examiner
‌
Maria G Leavitt
0
Edits on 27 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Mar, 2023
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
100238790
Date of Patent
July 17, 2018
0
Patent Application Number
147314030
Date Filed
June 4, 2015
0
Patent Citations Received
‌
US Patent 10517899 PD-L1 expressing hematopoietic stem cells and uses
0
‌
US Patent 10751373 PD-L1 expressing hematopoietic stem cells and uses
0
‌
US Patent 11319325 Macrocyclic spiropyrrolidine derived antiviral agents
0
‌
US Patent 11325916 Spiropyrrolidine derived antiviral agents
0
‌
US Patent 11339170 Spiropyrrolidine derived antiviral agents
0
‌
US Patent 11352363 Spiropyrrolidine derived antiviral agents
0
‌
US Patent 11358953 Functionalized peptides as antiviral agents
0
‌
US Patent 11384090 Spiropyrrolidine derived antiviral agents
0
Patent Primary Examiner
‌
Maria G Leavitt
0
Edits on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 13 Jul, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Jul, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11384090 Spiropyrrolidine derived antiviral agents
Edits on 16 Jun, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 16 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11358953 Functionalized peptides as antiviral agents

Find more entities like US Patent 10023879 Minimal volume reprogramming of mononuclear cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo